Abstract. Background Tendons are tough bands of dense and fibrous regular connective tissue that usually connect muscle to bone and are capable of withstanding tension (1). Tendons comprise of collagen bundles similar to those seen in ligaments (1).Tendinopathy is the most frequent tendon disorder (2-4) and is usually described as an over-use of tendons (5). Tendinopathy can develop in any tendon, but is most frequently found in the following tendons: Achilles, patellar, shoulder rotator cuff, and forearm extensor tendons (6). Tendonitis, a type of tendinopathy, is an inflammatory process in the tendon (5). Tendonitis often occurs in daily life and through sports, but tendon repair requires a long period of time because tendons have a low blood supply compared with other organs (7).Many challenging therapies, such as the use of nonsteroidal anti-inflammatory medications, eccentric exercises, topical glyceryl trinitrate, and shock-wave therapy, are performed to treat tendinopathy (8-11). Cell therapy is a new type of therapy for tendinopathy that occurs after tendon injury (12, 13). Recently, mesenchymal stem cell therapy, especially that using adipose-derived stem cells (ASCs), has emerged as a new therapeutic option for tendinopathy (14-16).Vitamin C is known to be a potent antioxidant (17) and can increase the viability of transplanted cells by reducing oxidative and inflammatory stress. Previous studies have revealed that vitamin C promoted tendon healing by stimulating extracellular matrix remodeling as a precursor of collagen synthesis (18,19). In addition, vitamin C increased the therapeutic effects of combination stem cell therapy in a muscle laceration model (20). However, there has been no study as far as we are aware on the therapeutic effects of combination stem cell therapy and vitamin C administration on tendinopathy.We hypothesized that combined therapy using ASCs and vitamin C might improve tendon regeneration in tendinopathy. To determine the combined effects of ASCs transplantation with vitamin C, we used senescence marker protein 30 (Smp30)-knockout mice that cannot biosynthesize vitamin C by themselves (21).
343